204 related articles for article (PubMed ID: 26365926)
1. Feasibility of Using Volumetric Contrast-Enhanced Ultrasound with a 3-D Transducer to Evaluate Therapeutic Response after Targeted Therapy in Rabbit Hepatic VX2 Carcinoma.
Kim J; Kim JH; Yoon SH; Choi WS; Kim YJ; Han JK; Choi BI
Ultrasound Med Biol; 2015 Dec; 41(12):3131-9. PubMed ID: 26365926
[TBL] [Abstract][Full Text] [Related]
2. Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results.
Frampas E; Lassau N; Zappa M; Vullierme MP; Koscielny S; Vilgrain V
Eur J Radiol; 2013 May; 82(5):e205-11. PubMed ID: 23273822
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US.
Sugimoto K; Moriyasu F; Saito K; Rognin N; Kamiyama N; Furuichi Y; Imai Y
Liver Int; 2013 Apr; 33(4):605-15. PubMed ID: 23305331
[TBL] [Abstract][Full Text] [Related]
4. Assessment of angiogenesis in rabbit orthotropic liver tumors using three-dimensional dynamic contrast-enhanced ultrasound compared with two-dimensional DCE-US.
Zheng Q; Zhang JC; Wang Z; Ruan SM; Li W; Pan FS; Chen LD; Zhang YC; Wu WX; Xie XY; Lu MD; Shan QY; Wang W
Jpn J Radiol; 2019 Oct; 37(10):701-709. PubMed ID: 31401722
[TBL] [Abstract][Full Text] [Related]
5. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound.
Zocco MA; Garcovich M; Lupascu A; Di Stasio E; Roccarina D; Annicchiarico BE; Riccardi L; Ainora ME; Ponziani F; Caracciolo G; Rapaccini GL; Landolfi R; Siciliano M; Pompili M; Gasbarrini A
J Hepatol; 2013 Nov; 59(5):1014-21. PubMed ID: 23811306
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.
Wang H; Hristov D; Qin J; Tian L; Willmann JK
Radiology; 2015 Nov; 277(2):424-34. PubMed ID: 26020439
[TBL] [Abstract][Full Text] [Related]
8. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
9. Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound.
Kong WT; Yuan HX; Cai H; Wang WP; Tang Y; Zhang XL
Tumour Biol; 2015 Apr; 36(4):2593-9. PubMed ID: 25448880
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Three-Dimensional Dynamic Contrast-Enhanced Ultrasound Imaging: First-In-Human Pilot Study in Patients with Liver Metastases.
El Kaffas A; Sigrist RMS; Fisher G; Bachawal S; Liau J; Wang H; Karanany A; Durot I; Rosenberg J; Hristov D; Willmann JK
Theranostics; 2017; 7(15):3745-3758. PubMed ID: 29109773
[No Abstract] [Full Text] [Related]
11. Evaluation of neovascularization with spectral computed tomography in a rabbit VX2 liver model: a comparison with real-time contrast-enhanced ultrasound and molecular biological findings.
Zhou Y; Gao JB; Xu H; Dong JQ; Wang MY
Br J Radiol; 2015; 88(1055):20140548. PubMed ID: 26456032
[TBL] [Abstract][Full Text] [Related]
12. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
Goetti R; Reiner CS; Knuth A; Klotz E; Stenner F; Samaras P; Alkadhi H
Invest Radiol; 2012 Jan; 47(1):18-24. PubMed ID: 21788906
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced ultrasound parametric maps to evaluate intratumoral vascularization.
Pitre-Champagnat S; Leguerney I; Bosq J; Peronneau P; Kiessling F; Calmels L; Coulot J; Lassau N
Invest Radiol; 2015 Apr; 50(4):212-7. PubMed ID: 25275834
[TBL] [Abstract][Full Text] [Related]
14. Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities.
Meijerink MR; van Waesberghe JH; van Schaik C; Boven E; van der Veldt AA; van den Tol P; Meijer S; van Kuijk C
Ultrasound Med Biol; 2010 Oct; 36(10):1626-36. PubMed ID: 20800954
[TBL] [Abstract][Full Text] [Related]
15. Assessment of response to sorafenib in advanced hepatocellular carcinoma using perfusion computed tomography: results of a pilot study.
Sacco R; Faggioni L; Bargellini I; Ginanni B; Battaglia V; Romano A; Bertini M; Bresci G; Bartolozzi C
Dig Liver Dis; 2013 Sep; 45(9):776-81. PubMed ID: 23578581
[TBL] [Abstract][Full Text] [Related]
16. Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation.
Eschbach RS; Clevert DA; Hirner-Eppeneder H; Ingrisch M; Moser M; Schuster J; Tadros D; Schneider M; Kazmierczak PM; Reiser M; Cyran CC
PLoS One; 2017; 12(1):e0169323. PubMed ID: 28060884
[TBL] [Abstract][Full Text] [Related]
17. Early response to anti-tumoral treatment in hepatocellular carcinoma--can quantitative contrast-enhanced ultrasound predict outcome?
Knieling F; Waldner MJ; Goertz RS; Zopf S; Wildner D; Neurath MF; Bernatik T; Strobel D
Ultraschall Med; 2013 Feb; 34(1):38-46. PubMed ID: 23258770
[TBL] [Abstract][Full Text] [Related]
18. Quantitative functional imaging by dynamic contrast enhanced ultrasonography (DCE-US) in GIST patients treated with masatinib.
Lassau N; Chami L; Koscielny S; Chebil M; Massard C; Benatsou B; Bidault S; Cioffi A; Blay JY; Le Cesne A
Invest New Drugs; 2012 Apr; 30(2):765-71. PubMed ID: 21136137
[TBL] [Abstract][Full Text] [Related]
19. Effect of an angiogenesis inhibitor on hepatic tumor perfusion and the implications for adjuvant cytotoxic therapy.
Stewart EE; Sun H; Chen X; Schafer PH; Chen Y; Garcia BM; Lee TY
Radiology; 2012 Jul; 264(1):68-77. PubMed ID: 22627603
[TBL] [Abstract][Full Text] [Related]
20. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
